LUCAT1 and renal carcinoma: The expression of DOCK8-AS1 was significantly decreased, while the expressions of those 4 signatures (SNHG17, RUSC1-AS1, LINC02609, and LUCAT1) were significantly increased in the patients with renal cancer (Supplementary Table S4).